Cargando…

Systematic Assessment of Immune Marker Variation in Type 1 Diabetes: A Prospective Longitudinal Study

Immune analytes have been widely tested in efforts to understand the heterogeneity of disease progression, risk, and therapeutic responses in type 1 diabetes (T1D). The future clinical utility of such analytes as biomarkers depends on their technical and biological variability, as well as their corr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Speake, Cate, Bahnson, Henry T., Wesley, Johnna D., Perdue, Nikole, Friedrich, David, Pham, Minh N., Lanxon-Cookson, Erinn, Kwok, William W., Sehested Hansen, Birgit, von Herrath, Matthias, Greenbaum, Carla J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753618/ https://www.ncbi.nlm.nih.gov/pubmed/31572352 http://dx.doi.org/10.3389/fimmu.2019.02023

Ejemplares similares

Peripheral autoreactive CD8 T‐cell frequencies are too variable to be a reliable predictor of disease progression of human type 1 diabetes
por: Wesley, Johnna D, et al.
Publicado: (2021)

Response to Comment on So et al. Autoantibody Reversion: Changing Risk Categories in Multiple-Autoantibody–Positive Individuals. Diabetes Care 2020;43:913–917
por: So, Michelle, et al.
Publicado: (2020)

A standardized metric to enhance clinical trial design and outcome interpretation in type 1 diabetes
por: Ylescupidez, Alyssa, et al.
Publicado: (2023)

Fitness Costs of Mutations at the HIV-1 Capsid Hexamerization Interface
por: Manocheewa, Siriphan, et al.
Publicado: (2013)

Low HLA binding of diabetes-associated CD8+ T-cell epitopes is increased by post translational modifications
por: Sidney, John, et al.
Publicado: (2018)

Non-antigenic and antigenic interventions in type 1 diabetes
por: Rydén, Anna KE, et al.
Publicado: (2013)

Early Prognostic Indicators of Subsequent Hospitalization in Patients with Mild COVID-19
por: Ylescupidez, Alyssa, et al.
Publicado: (2021)

Characterizing T cell responses to enzymatically modified beta cell neo-epitopes
por: Nguyen, Hai, et al.
Publicado: (2023)

P17-14. Fitness-informed HIV-1 Gag-p24 vaccine design
por: Rolland, MM, et al.
Publicado: (2009)

Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 Diabetes
por: Pham, Minh N., et al.
Publicado: (2016)

Hybrid Insulin Peptides Are Recognized by Human T Cells in the Context of DRB1*04:01
por: Arribas-Layton, David, et al.
Publicado: (2020)

Evaluation of Candidate Biomarkers of Type 1 Diabetes via the Core for Assay Validation
por: Speake, Cate, et al.
Publicado: (2015)

Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses
por: Manocheewa, Siriphan, et al.
Publicado: (2015)

ABCC8-Related Monogenic Diabetes Presenting Like Type 1 Diabetes in an Adolescent
por: Grier, Alexandra E., et al.
Publicado: (2023)

The Relationship of Immune Cell Signatures to Patient Survival Varies within and between Tumor Types
por: Linsley, Peter S., et al.
Publicado: (2015)

Foxp3(+) regulatory T cells maintain immune homeostasis in the skin
por: Dudda, Jan C., et al.
Publicado: (2008)

Innate immune activity as a predictor of persistent insulin secretion and association with responsiveness to CTLA4-Ig treatment in recent-onset type 1 diabetes
por: Cabrera, Susanne M., et al.
Publicado: (2018)

Malaria sporozoite proteome leaves a trail
por: Vignali, Marissa, et al.
Publicado: (2009)

Shifts in isoform usage underlie transcriptional differences in regulatory T cells in type 1 diabetes
por: Newman, Jeremy R. B., et al.
Publicado: (2023)

Copy Number Loss of the Interferon Gene Cluster in Melanomas Is Linked to Reduced T Cell Infiltrate and Poor Patient Prognosis
por: Linsley, Peter S., et al.
Publicado: (2014)

The many faces of islet antigen‐specific CD8 T cells: clues to clinical outcome in type 1 diabetes
por: Wiedeman, Alice E, et al.
Publicado: (2021)

Amino-Acid Co-Variation in HIV-1 Gag Subtype C: HLA-Mediated Selection Pressure and Compensatory Dynamics
por: Rolland, Morgane, et al.
Publicado: (2010)

Proinsulin Secretion Is a Persistent Feature of Type 1 Diabetes
por: Sims, Emily K., et al.
Publicado: (2019)

Response to Comment on Sims et al. Proinsulin Secretion Is a Persistent Feature of Type 1 Diabetes. Diabetes Care 2019;42:258–264
por: Sims, Emily K., et al.
Publicado: (2019)

T-bet(+) Treg Cells Undergo Abortive Th1 Cell Differentiation due to Impaired Expression of IL-12 Receptor β2
por: Koch, Meghan A., et al.
Publicado: (2012)

Atlas de histología y anatomía microscópica humanas
por: Herrath, E. von
Publicado: (1971)

Can We Learn From Viruses How to Prevent Type 1 Diabetes?: The Role of Viral Infections in the Pathogenesis of Type 1 Diabetes and the Development of Novel Combination Therapies
por: von Herrath, Matthias
Publicado: (2009)

Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease
por: Sather, Blythe D., et al.
Publicado: (2007)

T-bet controls regulatory T cell homeostasis and function during type-1 inflammation
por: Koch, Meghan A., et al.
Publicado: (2009)

A novel human mast cell activation test for peanut allergy
por: Santos, Alexandra F., et al.
Publicado: (2018)

Immunotherapy for the Prevention and Treatment of Type 1 Diabetes: Optimizing the path from bench to bedside
por: Bresson, Damien, et al.
Publicado: (2009)

Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential
por: Peakman, Mark, et al.
Publicado: (2010)

The Development of Immunotherapy Strategies for the Treatment of Type 1 Diabetes
por: Coppieters, Ken, et al.
Publicado: (2018)

Citrullination of glucokinase is linked to autoimmune diabetes
por: Yang, Mei-Ling, et al.
Publicado: (2022)

Biobanking, consent, and commercialization in international genetics research: the Type 1 Diabetes Genetics Consortium
por: Hall, Mark A, et al.
Publicado: (2010)

Lost in translation: barriers to implementing clinical immunotherapeutics for autoimmunity
por: von Herrath, Matthias G., et al.
Publicado: (2005)

Metabolic syndrome – Removing roadblocks to therapy: Antigenic immunotherapies()
por: Coppieters, Ken T., et al.
Publicado: (2014)

A Deeper Look into Type 1 Diabetes – Imaging Immune Responses during Onset of Disease
por: Christoffersson, Gustaf, et al.
Publicado: (2016)

The Type 1 Diabetes Signature: Hardwired to Trigger Inflammation?
por: Coppieters, Ken T., et al.
Publicado: (2014)

Immunosuppressive Mechanisms During Viral Infectious Diseases
por: Sarikonda, Ghanashyam, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_oktqo27iijtpuv0499r02icr7c